VanEck Associates
CLBT icon

VanEck Associates’s Cellebrite CLBT Stock Holding History

VanEck Associates’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$740K Buy
53,716
+7,743
+17% +$117K ﹤0.01% 1125
2025
Q4 		$829K Sell
45,973
-574
-1% -$10.3K ﹤0.01% 1100
2025
Q3 		$863K Sell
46,547
-3,000
-6% -$47.1K ﹤0.01% 1110
2025
Q2 		$793K Buy
49,547
+14,111
+40% +$252K ﹤0.01% 1094
2025
Q1 		$689K Buy
35,436
+6,448
+22% +$136K ﹤0.01% 1101
2024
Q4 		$639K Buy
+28,988
New +$558K ﹤0.01% 1104

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $200M AUM 30.56% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.75B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $942M AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.5B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return